Stratos Wealth Partners, Ltd. Neuro Sense Therapeutics Ltd. Transaction History
Stratos Wealth Partners, Ltd.
- $6.9 Billion
- Q4 2024
A detailed history of Stratos Wealth Partners, Ltd. transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 20,000 shares of NRSN stock, worth $22,599. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$22,599% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
14Shares Held
647KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il254KShares$287,0160.0% of portfolio
-
Morgan Stanley New York, NY103KShares$115,9160.0% of portfolio
-
Jane Street Group, LLC New York, NY64.6KShares$73,0380.0% of portfolio
-
Hrt Financial LP New York, NY64.4KShares$72,7600.0% of portfolio
-
Xtx Topco LTD London, X041.9KShares$47,3430.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $13.2M